Primo Nutraceuticals Inc. (BUGVF) Stock

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. focuses on acquiring and developing commercial real estate assets in Canada, specifically tailored for the cannabis cultivation sector. The company delivers comprehensive, ready-to-use facilities, integrated with all necessary infrastructure, for cannabis producers and processors. Furthermore, it holds a hemp project in Oregon and operates a greenhouse complex situated in Washington state. Established in 2014, the firm adopted its current name, Primo Nutraceuticals Inc., in October 2019, having previously been known as Bougainville Ventures Inc. Its corporate base is located in Vancouver, Canada.

Primo Nutraceuticals Inc. (BUGVF) stock trades at $0.00 with a market capitalization of $26. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Primo Nutraceuticals Inc. generates a return on equity (ROE) of 400.00% — well above the market average, a sign of a high-quality business, return on capital employed of 219.05%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.primonutraceuticals.com